Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019…

@Ham_Den_Vilde @zhiyanle @pathogenetics This was the Study https://t.co/ViW1AwApgW

@jeanfra60859785 @boss21235248 @TrampolineJ @PrimoR14414242 @David_vanH Alors pubmed qui permet aux pro de santé du monde entier de se tenir informé des diverses avancées en médecine regroupe la quasi totalité des études fiables et indépendante dont une ét

@SFuksalot @TXwoods04 @2AlwaysQuestion @Benioff @jimcramer And ive heard from doctors out there that have used the HCQ protocol and it works in the early to moderate stages pf covid infections . And people recovered! Even Norway did a study and said it wo

@Trophy4toon @marc_tacy @EadeDebbie @ClarkeMicah @CllrBSilvester @BreesAnna Most trials - e.g. https://t.co/BOYKE0xe0Y or https://t.co/BGiybDBwbJ - have been done with 400mg, twice daily. Did someone misread 2x400mg as 2,400mg?

New article: Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A… https://t.co/rObLkIkZrL #coronavirus #C